Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 10Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Rhabdomyosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Desmoplastic Small Round Cell Tumor 2Brain Neoplasms 2Stage IA Uterine Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Malignant mesenchymal tumor 1Liposarcoma 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Endometrial Clear Cell Adenocarcinoma 1Carcinosarcoma 1Astrocytoma 1

Interventions

Ifosfamide 30Methotrexate 29Doxorubicin 26Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10Specimen Handling 10cabozantinib 9apatinib 9X-Rays 9Carboplatin 9fludarabine 8Radiotherapy 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Drug Therapy 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Phantoms, Imaging 7Biopsy 7mifamurtide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Brachytherapy × Sarcoma × Clear all
NCT06524778 2024-08-07

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phase 2 Not yet recruiting
16 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡